Achilles Therapeutics (ACHL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov15

Achilles Therapeutics released FY2024 Cumulative 3Q Earnings on November 14 (EST), Revenue: 0, EPS: -1.1952

04:00

Achilles Therapeutics released FY2024 Q3 earnings on November 14 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -0.4846 USD (forecast -0.455 USD)

04:00

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Net Income -19.6 M, EPS -0.4846

Aug14

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Net Income -16.38 M, EPS -0.4058

May8

Earning Release(EST)

FY2024 Q1 Earning Release (USD) Net Income -12.27 M, EPS -0.3047

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change